TYK 2 inhibitors for the treatment of dermatologic conditions: the evolution of JAK inhibitors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

TYK 2 inhibitors for the treatment of dermatologic conditions: the evolution of JAK inhibitors

Published:2021-04-30 Issue:2 Volume:61 Page:139-147
ISSN:0011-9059
Container-title:International Journal of Dermatology
language:en
Short-container-title:Int J Dermatology

Author:

Jo Christine E.¹,Gooderham Melinda²³⁴,Beecker Jennifer⁴⁵

Affiliation:

1. Faculty of Medicine University of Ottawa Ottawa Ontario Canada

2. Department of Medicine Queen's University Kingston Ontario Canada

3. SKiN Centre for Dermatology Peterborough Ontario Canada

4. Probity Medical Research Inc. Waterloo Ontario Canada

5. Division of Dermatology University of Ottawa Ottawa Ontario Canada

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ijd.15605

Reference70 articles.

1. Selective Janus kinase inhibitors come of age

2. The molecular regulation of Janus kinase (JAK) activation

3. Selective JAKinibs: Prospects in Inflammatory and Autoimmune Diseases

4. JAK inhibition as a therapeutic strategy for immune and inflammatory diseases

5. JAK/STAT pathway modulation: Does it work in dermatology?

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Concise synthesis of pyridopyridazines;Tetrahedron Letters;2024-10

2. SOCS-JAK-STAT inhibitors and SOCS mimetics as treatment options for autoimmune uveitis, psoriasis, lupus, and autoimmune encephalitis;Frontiers in Immunology;2023-10-26

3. In silico computational drug discovery: a Monte Carlo approach for developing a novel JAK3 inhibitors;Journal of Biomolecular Structure and Dynamics;2023-10-20

4. Recent advances in uveitis therapy: focus on selected phase 2 and 3 clinical trials;Expert Opinion on Emerging Drugs;2023-10-02

5. Efficacy and safety of abrocitinib for the treatment of adolescents and adults with moderate-to-severe atopic dermatitis: update of a living systematic review and meta-analysis;European Journal of Dermatology;2023-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3